So if I expect Keytruda to be a $10 billion product, does that justify aggressively buying MRK? I have no clue on the valuations of these big pharma - when I take a superficial look at the numbers the stock doesn't look that cheap.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.